根据《关于在上市公司建立独立董事的指导意见》、《上市公司治理原则》、 《公司章程》及《独立董事工作制度》等有关规定，本着独立、客观、公正的原 则，经过审慎认真的研究，我们就公司第五届董事会第十六次会议召开前对本次 会议的相关议案进行了认真审核，基于独立判断，发表事前认可意见如下： 重庆三圣实业股份有限公司独立董事 关于第五届董事会第十六次会议有关事项的事前认可意见 独立董事：张孝友 付海平 李有光 2025 年 4 月 25 日 我们对此项议案进行了认真的事前审核，详细了解了天健会计师事务所（特 殊普通合伙）具备的证券、期货相关业务执业资格和历年对公司提供财务、内控 审计服务的情况，一致同意将此项议案提交公司董事会审议。 一、同意将《关于公司聘请 2025 年度财务审计机构的议案》提交公司董事 会审议 ...

重庆三圣实业股份有限公司独立董事 公司在《2024 年度内部控制评价报告》中对公司为加强和完善内部控制所 进行的重要工作等情况作了介绍，对内部控制的建立健全和有效运行进行了认真 核查，真实反映了公司内部控制的基本情况。 我们认为，公司存在控股股东、实际控制人规范意识不足，凌驾于公司内部 控制之上；同时公司相关经办人员风险意识淡薄，顺从控股股东、实际控制人的 意图，未能有效执行公司内部控制制度。根据公司财务报告内部控制重大、重要 缺陷的认定标准，结合《企业内部控制基本规范》及相关规定，公司在关联交易 决策、资金管理、借款和担保、信息披露等方面存在内部控制重大缺陷。 关于对第五届董事会第十六次会议 有关事项的独立意见 根据《上市公司独立董事规则》、《上市公司治理准则》、《公司章程》及 《独立董事工作制度》等有关规定，本着独立、客观、公正的原则，经过审慎认 真的研究，我们就公司 2024 年度报告及第五届董事会第十六次会议有关事项发 表如下独立意见： 一、关于公司 2024 年度利润分配预案的独立意见 公司 2024 年度利润分配预案为：因本年度公司亏损，故不进行公积金转增 股本，不进行利润分配。 我们认为，该预案 ...

Financial Performance - The company's operating revenue for Q1 2025 was ¥234,934,455.67, a decrease of 32.52% compared to ¥348,149,625.80 in the same period last year[5] - The net loss attributable to shareholders was ¥82,377,602.48, representing a 132.59% increase in loss from ¥35,416,918.24 year-on-year[5] - The basic and diluted earnings per share were both -¥0.1907, reflecting a 132.56% increase in loss per share compared to -¥0.0820 last year[5] - Net profit for the current period was a loss of CNY 84,754,826.81, compared to a loss of CNY 23,366,712.36 in the previous period, indicating a significant increase in losses[19] - The total comprehensive income for the period was -82,319,754.62, compared to -24,218,581.28 in the previous period, indicating a significant decline[20] Cash Flow - The net cash flow from operating activities improved to ¥13,430,875.49, a significant increase of 174.27% from -¥18,083,861.22 in the previous year[5] - The net cash flow from investing activities showed a net outflow of ¥6,340,714.41, a 54.44% improvement from -¥13,915,984.45 in the previous year[9] - Cash inflow from sales of goods and services was 270,889,669.32, up from 204,465,082.87, reflecting a growth of approximately 32.4%[21] - The cash outflow for purchasing goods and services was 120,486,565.56, down from 171,561,464.04, suggesting cost control measures[21] - The company received tax refunds amounting to 1,248,798.11, up from 112,820.97, which may positively impact cash flow[21] Assets and Liabilities - Total assets decreased by 4.51% to ¥2,507,608,127.92 from ¥2,626,041,333.84 at the end of the previous year[5] - Total liabilities increased to CNY 2,891,741,565.35 from CNY 2,855,055,016.65, an increase of 1.3%[16] - The company's cash and cash equivalents decreased to CNY 75,097,153.02 from CNY 88,868,835.48, a decline of 15.5%[14] - Accounts receivable decreased to CNY 474,881,087.93 from CNY 548,715,601.12, a reduction of 13.4%[14] - Inventory decreased slightly to CNY 224,883,663.92 from CNY 229,037,106.01, a decrease of 1.8%[15] Financial Ratios and Returns - The company's weighted average return on equity improved to 18.14%, up by 28.98% from -10.84% in the previous year[5] - The company's retained earnings showed a decline, with an accumulated loss of CNY 933,561,157.71 compared to CNY 851,183,555.23 in the previous period[16] - The company reported financial expenses of CNY 53,878,808.46, an increase from CNY 39,829,014.33 in the previous period, reflecting a rise of 35.3%[19] Operational Focus - The company did not execute any significant acquisitions or new product launches during this reporting period, focusing instead on operational improvements[23] - The company recorded a 3176.69% increase in non-operating income to ¥581,638.79, mainly from asset disposal income[9]

Financial Performance - The company's operating revenue for 2024 was ¥1,195,718,179.72, a decrease of 41.10% compared to ¥2,030,233,466.71 in 2023[6]. - The net profit attributable to shareholders for 2024 was -¥650,130,617.85, representing a decline of 43.82% from -¥452,046,680.05 in 2023[6]. - The basic earnings per share for 2024 was -¥1.50, down 42.86% from -¥1.05 in 2023[6]. - The total assets at the end of 2024 were ¥2,626,041,333.84, a reduction of 31.63% from ¥3,841,158,437.01 at the end of 2023[6]. - The company's cash flow from operating activities for 2024 was -¥47,018,889.30, an improvement of 8.87% compared to -¥51,594,597.21 in 2023[6]. - The company's net assets attributable to shareholders at the end of 2024 were -¥411,810,939.89, a decrease of 219.27% from ¥345,287,512.91 at the end of 2023[6]. - The company's total revenue for 2024 was ¥1,195,718,179.72, representing a year-on-year decrease of 41.10% from ¥2,030,233,466.7 in 2023[42]. - The construction materials and chemicals segment generated ¥544,051,627.22, accounting for 45.50% of total revenue, down 47.53% from ¥1,036,797,546.46 in 2023[45]. - The pharmaceutical segment contributed ¥625,260,185.91, which is 52.29% of total revenue, reflecting a decrease of 35.31% from ¥966,477,588.69 in 2023[45]. - Domestic revenue was ¥953,817,087.21, making up 79.77% of total revenue, a decline of 45.36% from ¥1,745,760,779.90 in 2023[45]. Internal Control and Audit - The company reported a significant internal control deficiency in areas such as related party transactions, fund management, and information disclosure, which has affected the reliability of its financial reporting[4]. - The company's financial report has received a qualified audit opinion from Tianjian Accounting Firm, indicating potential issues in financial accuracy[4]. - The company's financial reporting and internal control deficiencies have been detailed in the 2024 Internal Control Self-Assessment Report[4]. - The internal control system has been improved to adapt to changing external environments and internal management requirements[112]. - San Sheng Co. failed to maintain effective internal control over financial reporting as of December 31, 2024, according to the internal control audit report[116]. - The internal control audit report issued by the accounting firm contains a negative opinion due to significant internal control deficiencies related to related party transactions and fund management[117]. - The company reported two significant defects in financial reporting internal controls during the evaluation period[115]. Business Strategy and Development - The company has expanded its business into the pharmaceutical manufacturing sector, acquiring 100% of Baikang Pharmaceutical in June 2016 and 60% of Chunrui Chemical in June 2017[19]. - The pharmaceutical manufacturing industry is a key focus for the company, aligning with national policies aimed at enhancing healthcare and economic development[32]. - The company has completed a full industry chain layout in pharmaceutical research and development, intermediates, active pharmaceutical ingredients, and formulations through diversification strategies and acquisitions[33]. - The company operates primarily in the construction materials sector, heavily influenced by macroeconomic conditions and infrastructure investments[30]. - The company's diversified strategy has effectively reduced operational risks associated with macroeconomic cycles, enhancing overall business stability[36]. - The company has established a dual-driven business model of "construction materials and chemicals + pharmaceutical manufacturing," effectively reducing the impact of raw material price fluctuations[41]. - The company aims to strengthen its innovation capabilities and improve economic efficiency and core competitiveness through ongoing research and development efforts[44]. Environmental Compliance - San Sheng Co. strictly complied with multiple environmental protection laws and standards in 2024, including the Air Pollution Prevention and Control Law and the Water Pollution Prevention and Control Law[120]. - The company reported a total emission of 2.689 tons of particulate matter, which is within the regulatory limits set by the relevant standards[121]. - The company achieved a total phosphorus discharge of 2.22 t/a, adhering to the standard of ≤40 mg/L[123]. - The company has set a target to reduce total nitrogen emissions to 1.36 t/a in the upcoming year[123]. - The company plans to enhance its wastewater treatment capacity to further lower COD levels to 21.0 t/a[123]. - The company is focusing on improving its air quality management by reducing VOCs emissions by 10% in the next fiscal year[123]. - The company has implemented automatic online monitoring systems for waste gas and wastewater treatment facilities to ensure compliance with national and industry standards[127]. Governance and Management - The company has maintained a stable leadership team with no resignations or dismissals reported during the current term[89]. - The current board includes professionals with backgrounds in engineering, finance, and management, enhancing the company's strategic capabilities[90][92][93]. - The independent directors bring diverse expertise, contributing to robust governance and strategic oversight[90][91]. - The company is committed to maintaining transparency and accountability in its operations, as evidenced by the structured reporting of management changes[88]. - The total pre-tax remuneration for directors, supervisors, and senior management in the reporting period amounted to CNY 597.46 million[99]. - The remuneration for the chairman, Yan Huan, was CNY 48.28 million, while the total remuneration for the general manager, Zhang Zhiqiang, was CNY 115.88 million[98]. - The company has established a performance-oriented compensation system, including base salary, performance bonuses, and incentives to motivate employees[107]. Legal and Financial Issues - The company is facing significant financial pressure and has applied for bankruptcy reorganization[79]. - The company is involved in a legal dispute regarding a loan of 100 million, with a total repayment obligation of 61.485 million, including principal and interest[153]. - The company has been under administrative supervision multiple times since 2020 due to non-operating fund occupation and irregular guarantees[139]. - The company has incurred a financial cost of RMB 38.78 million due to the occupation of funds calculated until November 5, 2024[139]. - The company is currently in discussions regarding the repayment strategy for the outstanding loan[138]. - The company has recognized a provision for expected liabilities amounting to RMB 1,524.04 million related to SSC Construction PLC's debts[139]. - The company has been involved in multiple legal disputes regarding loans and guarantees, impacting its financial position and liquidity[195].

证券代码：002742 证券简称：ST三圣 公告编号：2025-25号 重庆三圣实业股份有限公司 关于控股股东股份新增轮候冻结的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 特别风险提示： 控股股东累计被冻结股份数量（含本次）占其所持公司股份数量比例超过 80%，请投资者注意相关风险。 重庆三圣实业股份有限公司（以下简称"公司"）于近日通过中国证券登记 结算有限责任公司系统查询，获悉控股股东潘先文先生所持公司股份存在新增轮 候冻结情形,现将具体情况公告如下： 二、股东股份累计冻结情况 | 股东名称 | 持股数量 | 持股比例 | 累计被司法冻结 | 占其所持股份比 | 占公司总股本 | | --- | --- | --- | --- | --- | --- | | | | （%） | 数量 | 例（%） | 比例（%） | | 潘先文 | 104,554,232 | 24.21 | 104,554,232 | 100 | 24.21 | （二）截至本公告披露日，上述股东所持股份累计被轮候冻结的情况如 下： 股东名 称 是否为第 一大股东 及一致行 动人 ...

一、协议履行进展 近日，为顺利推进三圣股份重整程序，公司与深圳高新投集团在平等、自愿、 协商一致的基础上，针对《执行和解协议》解除条款做出部分变更并达成如下补 充协议（以下简称 "本补充协议"），以兹共同遵守： 证券代码：002742 证券简称：ST 三圣 公告编号：2025-24 号 重庆三圣实业股份有限公司 关于签署《执行和解协议之补充协议》的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 重庆三圣实业有限公司（以下简称"公司"或"三圣股份"）于 2024 年 12 月 18 日与深圳市高新投集团有限公司（以下简称"深圳高新投集团"签署《执 行和解协议》，详见公司于 2024 年 12 月 19 日在巨潮资讯网上披露的《关于签 署<执行和解协议>的公告》（公告编号：2024-94 号）。 3、本补充协议是《执行和解协议》的补充协议，与《执行和解协议》具有 同等效力，系《执行和解协议》不可分割的一部分。本补充协议与《执行和解协 议》不一致之处，以本补充协议为准；本补充协议未约定的事项，以《执行和解 协议》约定为准。 二、本次协议对公司的影响 《执行和解 ...

证券代码：002742 证券简称：ST 三圣 公告编号：2025-22 号 针对公司股票交易异常波动，现将相关情况说明如下： 1、公司、控股股东和实际控制人不存在关于公司的应披露而未披露的重大 事项，或处于筹划阶段的重大事项。 2、公司前期所披露的信息，不存在需要更正、补充之处。 3、公司未发现近期公共媒体报道了可能或已经对公司股票交易价格产生较 大影响的未公开重大信息。 4、公司已披露的经营情况、内外部经营环境未发生重大变化。 5、公司控股股东、实际控制人在股票交易波动期间不存在买卖公司股票的 情形。 重庆三圣实业股份有限公司 股票交易异常波动公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、股票交易异常波动的情况介绍 重庆三圣实业股份有限公司（以下简称"公司"）股票（证券简称：ST 三 圣，证券代码：002742）日收盘价格涨跌幅偏离值累计异常，2025 年 4 月 11 日、 2025 年 4 月 14 日、2025 年 4 月 15 日，连续 3 个交易日收盘价涨幅偏离值累计 达到 13.82%。根据《深圳证券交易所交易规则》的有关规定，属于股 ...

证券代码：002742 证券简称：ST 三圣 公告编号：2025-23 号 重庆三圣实业股份有限公司 关于公司股票交易可能被实施 退市风险警示的提示性公告 根据公司于 2025 年 1 月 21 日在巨潮资讯网（www.cninfo.com.cn）披露的 《2024 年年度业绩预告的补充公告》，预计 2024 年度公司期末净资产为-39,000 万元至-26,000 万元。根据《深圳证券交易所股票上市规则》9.3.1 第一款第（二） 项的规定，上市公司出现"最近一个会计年度经审计的期末净资产为负值"的情 形，公司股票交易将在 2024 年年度报告披露后被实施退市风险警示（在股票简 称前冠以*ST 字样）。 根据《深圳证券交易所股票上市规则》9.3.3 的规定："上市公司预计将出 现本规则第 9.3.1 条第一款第一项至第三项情形的，应当在相应的会计年度结束 后一个月内，披露公司股票交易可能被实施退市风险警示的风险提示公告，并在 披露年度报告前至少再披露两次风险提示公告。" 二、其他说明 1、截至本公告披露日，公司 2024 年度审计工作仍在推进当中，具体财务数 据以公司正式披露的经审计的 2024 年年度报告 ...

ST三圣（002742）公告，公司预计2024年度期末净资产为-3.9亿元至-2.6亿元。根据《深圳证券交易所 股票上市规则》相关规定，公司股票交易将在2024年年度报告披露后被实施退市风险警示。 ...

ST三圣（002742）发布异动公告，公司、控股股东和实际控制人不存在应披露而未披露的重大事项， 或处于筹划阶段的重大事项。公司前期所披露的信息，不存在需要更正、补充之处。公司未发现近期公 共媒体报道了可能或已经对公司股票交易价格产生较大影响的未公开重大信息。公司已披露的经营情 况、内外部经营环境未发生重大变化。 ...